Literature DB >> 19171919

A high-throughput ligand competition binding assay for the androgen receptor and other nuclear receptors.

Clémentine Féau1, Leggy A Arnold, Aaron Kosinski, R Kiplin Guy.   

Abstract

Standardized, automated ligand-binding assays facilitate evaluation of endocrine activities of environmental chemicals and identification of antagonists of nuclear receptor ligands. Many current assays rely on fluorescently labeled ligands that are significantly different from the native ligands. The authors describe a radiolabeled ligand competition scintillation proximity assay (SPA) for the androgen receptor (AR) using Ni-coated 384-well FlashPlates and liganded AR-LBD protein. This highly reproducible, low-cost assay is well suited for automated high-throughput screening. In addition, the authors show that this assay can be adapted to measure ligand affinities for other nuclear receptors (peroxisome proliferation-activated receptor gamma, thyroid receptors alpha and beta).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171919      PMCID: PMC2632761          DOI: 10.1177/1087057108326662

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  13 in total

1.  Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.

Authors:  P M Matias; P Donner; R Coelho; M Thomaz; C Peixoto; S Macedo; N Otto; S Joschko; P Scholz; A Wegg; S Bäsler; M Schäfer; U Egner; M A Carrondo
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 2.  Production and purification of histidine-tagged dihydrotestosterone-bound full-length human androgen receptor.

Authors:  M Liao; E M Wilson
Journal:  Methods Mol Biol       Date:  2001

Review 3.  Effects of environmental antiandrogens on reproductive development in experimental animals.

Authors:  L E Gray; J Ostby; J Furr; C J Wolf; C Lambright; L Parks; D N Veeramachaneni; V Wilson; M Price; A Hotchkiss; E Orlando; L Guillette
Journal:  Hum Reprod Update       Date:  2001 May-Jun       Impact factor: 15.610

4.  A high-throughput screening method to identify small molecule inhibitors of thyroid hormone receptor coactivator binding.

Authors:  Leggy A Arnold; Eva Estébanez-Perpiñá; Marie Togashi; Anang Shelat; Cory A Ocasio; Andrea C McReynolds; Phuong Nguyen; John D Baxter; Robert J Fletterick; Paul Webb; R Kiplin Guy
Journal:  Sci STKE       Date:  2006-06-27

5.  Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.

Authors:  B A Janowski; M J Grogan; S A Jones; G B Wisely; S A Kliewer; E J Corey; D J Mangelsdorf
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

6.  An ultrahigh-throughput screening assay for estrogen receptor ligands.

Authors:  G F Allan; A Hutchins; J Clancy
Journal:  Anal Biochem       Date:  1999-11-15       Impact factor: 3.365

7.  Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphatase.

Authors:  Tammy C Turek-Etienne; Eliza C Small; Sharon C Soh; Tianpei A Xin; Priti V Gaitonde; Ellen B Barrabee; Richard F Hart; Robert W Bryant
Journal:  J Biomol Screen       Date:  2003-04

8.  Development and standardization of a simple binding assay for the detection of compounds with affinity for the androgen receptor.

Authors:  Alexius Freyberger; Hans-Jürgen Ahr
Journal:  Toxicology       Date:  2004-02-15       Impact factor: 4.221

9.  A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor.

Authors:  G Chiellini; J W Apriletti; H A Yoshihara; J D Baxter; R C Ribeiro; T S Scanlan
Journal:  Chem Biol       Date:  1998-06

10.  Single-step purification of full-length human androgen receptor.

Authors:  Dalia Juzumiene; Ching-yi Chang; Daju Fan; Tanya Hartney; John D Norris; Donald P McDonnell
Journal:  Nucl Recept Signal       Date:  2005-10-21
View more
  10 in total

1.  Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening.

Authors:  Nathan A Lack; Peter Axerio-Cilies; Peyman Tavassoli; Frank Q Han; Ka Hong Chan; Clementine Feau; Eric LeBlanc; Emma Tomlinson Guns; R Kiplin Guy; Paul S Rennie; Artem Cherkasov
Journal:  J Med Chem       Date:  2011-11-18       Impact factor: 7.446

2.  Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978.

Authors:  Chunkai Wang; Qingjie Zhao; Jaeki Min; Sakthivel Muniyan; Mireille Vargas; Xiaofang Wang; Yuxiang Dong; R Kiplin Guy; Ming-Fong Lin; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

3.  Ligand fishing using new chitosan based functionalized Androgen Receptor magnetic particles.

Authors:  Michał Piotr Marszałł; Wiktor Dariusz Sroka; Adam Sikora; Dorota Chełminiak; Marta Ziegler-Borowska; Tomasz Siódmiak; Ruin Moaddel
Journal:  J Pharm Biomed Anal       Date:  2016-05-04       Impact factor: 3.935

4.  Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone.

Authors:  Jong Yeon Hwang; Wenwei Huang; Leggy A Arnold; Ruili Huang; Ramy R Attia; Michele Connelly; Jennifer Wichterman; Fangyi Zhu; Indre Augustinaite; Christopher P Austin; James Inglese; Ronald L Johnson; R Kiplin Guy
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

5.  Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPTs) as thyroid hormone receptor-coactivator interaction inhibitors.

Authors:  Jong Yeon Hwang; Ramy R Attia; Fangyi Zhu; Lei Yang; Andrew Lemoff; Cynthia Jeffries; Michele C Connelly; R Kiplin Guy
Journal:  J Med Chem       Date:  2012-02-23       Impact factor: 7.446

6.  Synthesis and structure-activity relationship studies of novel dihydropyridones as androgen receptor modulators.

Authors:  Antonella Pepe; Michael Pamment; Yeong Sang Kim; Sunmin Lee; Min-Jung Lee; Kristin Beebe; Anton Filikov; Len Neckers; Jane B Trepel; Sanjay V Malhotra
Journal:  J Med Chem       Date:  2013-10-30       Impact factor: 7.446

Review 7.  Fluorescence anisotropy (polarization): from drug screening to precision medicine.

Authors:  Hairong Zhang; Qian Wu; Mikhail Y Berezin
Journal:  Expert Opin Drug Discov       Date:  2015-08-03       Impact factor: 6.098

8.  Novel flufenamic acid analogues as inhibitors of androgen receptor mediated transcription.

Authors:  Clémentine Féau; Leggy A Arnold; Aaron Kosinski; Fangyi Zhu; Michele Connelly; R Kiplin Guy
Journal:  ACS Chem Biol       Date:  2009-10-16       Impact factor: 5.100

9.  Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.

Authors:  Ashley T Fancher; Yun Hua; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2019-09-06       Impact factor: 1.738

10.  Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo.

Authors:  Negar Khazan; Kyu Kwang Kim; Jeanne N Hansen; Niloy A Singh; Taylor Moore; Cameron W A Snyder; Ravina Pandita; Myla Strawderman; Michiko Fujihara; Yuta Takamura; Ye Jian; Nicholas Battaglia; Naohiro Yano; Yuki Teramoto; Leggy A Arnold; Russell Hopson; Keshav Kishor; Sneha Nayak; Debasmita Ojha; Ashoke Sharon; John M Ashton; Jian Wang; Michael T Milano; Hiroshi Miyamoto; David C Linehan; Scott A Gerber; Nada Kawar; Ajay P Singh; Erdem D Tabdanov; Nikolay V Dokholyan; Hiroki Kakuta; Peter W Jurutka; Nina F Schor; Rachael B Rowswell-Turner; Rakesh K Singh; Richard G Moore
Journal:  J Med Chem       Date:  2022-04-11       Impact factor: 8.039

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.